Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
Clinical trial NCT02460367 · TERMINATED
Trial details
- NCT number
- NCT02460367
- Sponsor
- NewLink Genetics Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-07-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.